Discovery of drugs suitable for the treatment of Waldenstrm Macroglobulinemia

Researchers

Grant status

Active

Grant start date

01/07/2021

Grant funding

  • 2021: $106,500 from Canberra Health Services

Updated:  02 December 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers